PROTOCOL OF BLEEDING CONTROL IN PATIENTS TAKING NEW ORAL ANTICOAGULANTS (NOACS)

被引:0
|
作者
Goncalves Ricca, L. [1 ]
Guerreiro, M. [1 ]
Martinez, F. [1 ]
Araujo, F. [1 ]
机构
[1] Sao Joao Univ Hosp, Transfus Med & Blood Bank Dept, Oporto, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C0276
引用
收藏
页码:S87 / S87
页数:1
相关论文
共 50 条
  • [11] Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants
    Barcellona, Doris
    Fenu, L.
    Marongiu, F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 134 - 137
  • [12] Coagulation Assays in Patients with New Oral Anticoagulants (NOACs): Why? When?
    Samama, Meyer Michel
    DRUG DEVELOPMENT RESEARCH, 2013, 74 (08) : 582 - 586
  • [13] Bleeding management in patients with new oral anticoagulants
    Vargas, Maria
    Marra, Annachiara
    Perrone, Antonietta
    Servillo, Giuseppe
    MINERVA ANESTESIOLOGICA, 2016, 82 (08) : 884 - 894
  • [14] The new oral anticoagulants (NOACs). Why should we control their anticoagulant activity?
    Altman, Raul
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2014, 43 (02): : 60 - 63
  • [15] Bleeding and Thrombosis With New Oral Anticoagulants (Noacs): Analysis of Four Years of Spontaneous Reports in France
    Lillo-Le Louet, A.
    Laine, P.
    DRUG SAFETY, 2013, 36 (09) : 841 - 841
  • [16] The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
    Udayachalerm, Sariya
    Rattanasiri, Sasivimol
    Angkananard, Teeranan
    Attia, John
    Sansanayudh, Nakarin
    Thakkinstian, Ammarin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 : 117S - 126S
  • [17] NOACS: NOVEL ORAL ANTICOAGULANTS - NEW OPPORTUNITIES IN RHEUMATOLOGY?
    Cohen, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 48 - 49
  • [18] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Sebastian Werth
    Tomás Breslin
    Fionnuala NiAinle
    Jan Beyer-Westendorf
    American Journal of Cardiovascular Drugs, 2015, 15 : 235 - 242
  • [19] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Werth, Sebastian
    Breslin, Tomas
    NiAinle, Fionnuala
    Beyer-Westendorf, Jan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (04) : 235 - 242
  • [20] Beware of hepatotoxicity risk with new oral anticoagulants (NOACs)
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2016, 32 (3) : 113 - 118